JO
NEXI

John Overdeck’s NexImmune, Inc. Common Stock NEXI Stock Holding History

John Overdeck’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-403
Closed -$2.12K – 3440
2023
Q3 		$2.12K Sell
403
-500
-55% -$3.1K ﹤0.01% 2924
2023
Q2 		$6.36K Sell
903
-643
-42% -$5.54K ﹤0.01% 2956
2023
Q1 		$14.7K Buy
+1,546
New +$16.2K ﹤0.01% 2871
2022
Q1 		– Sell
-510
Closed -$59K – 4622
2021
Q4 		$59K Buy
+510
New +$123K ﹤0.01% 4129

Other funds holding NEXI

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

John Overdeck's NEXI Position: Q4 2023 in Review

John Overdeck sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 403 shares — an estimated $2.12K sold.

John Overdeck first reported a position in NEXI in Q4 2021 and held it in 4 quarters. The position peaked at $59K in Q4 2021. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

  • John Overdeck reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • John Overdeck sold 403 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $2.12K.
  • John Overdeck first reported a position in NexImmune, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • John Overdeck's NexImmune, Inc. Common Stock position peaked at $59K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.